$127 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 9 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TRVN | Trevena, Inc. | $28,027,000 | +1.4% | 2,669,280 | 0.0% | 22.02% | +17.0% | |
| TTOO | T2 Biosystems, Inc. | $22,082,000 | +24.9% | 2,018,450 | 0.0% | 17.35% | +44.0% | |
| LIFE | Atyr Pharma Inc. | $17,969,000 | -4.2% | 1,827,992 | 0.0% | 14.12% | +10.5% | |
| PULM | Pulmatrix Inc. | $15,154,000 | -14.5% | 3,607,996 | 0.0% | 11.90% | -1.4% | |
| OCUL | Ocular Therapeutix, Inc. | $11,525,000 | -33.4% | 1,230,009 | 0.0% | 9.05% | -23.2% | |
| GNCA | Genocea Biosciences, Inc. | $10,375,000 | -23.1% | 1,968,606 | 0.0% | 8.15% | -11.3% | |
| CERU | Cerulean Pharma Inc | $9,205,000 | -23.5% | 3,287,529 | 0.0% | 7.23% | -11.8% | |
| FATE | Fate Therapeutics, Inc. | $8,335,000 | -36.8% | 2,473,186 | 0.0% | 6.55% | -27.1% | |
| BINDQ | Bind Therapeutics, Inc. | $4,622,000 | -48.7% | 2,018,253 | 0.0% | 3.63% | -40.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
| Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
| Trevena, Inc. | 22 | Q2 2019 | 24.9% |
| Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
| Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
| T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
| Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
| Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
| Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
| Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2022-03-30 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-14 |
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.